Navin Fluorine Reports Robust H1 FY27 Results and Expands Strategic Capex
Navin Fluorine International Ltd 路 Intimation 路 11 Nov 2026, 8:04 pm
Navin Fluorine Reports Robust H1 FY27 Results and Expands Strategic Capex Navin Fluorine posted strong H1 FY27 consolidated revenue of Rs 2,235.82 Cr (up 50.68% YoY) and PAT of Rs 512.55 Cr (up 93.02% YoY), driven by growth across HPP (+41%), Specialty Chemicals (+53%), and CDMO (+80%). Q2 FY27 revenue rose 57.00% YoY to Rs 1,190.74 Cr with operating EBITDA margins at 34.22%. Growth initiatives remain robust, including an extended HFO contract with Solstice adding ~$180 million, a 15,000 MTPA R32 expansion, the Rs 120 Cr Chemours project, and the Rs 125 Cr Phase II cGMP4 expansion commissioning by Q4 FY27.
Original exchange filing (PDF)
More announcements from Navin Fluorine International Ltd
- Intimation of Schedule of Analyst / Institutional Investor Meets 路 13 Nov 2026
- Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 路 13 Nov 2026
- Transcript of Earnings Call held for the quarter and half year ended September 30, 2026 路 06 Nov 2026
- Newspaper Advertisement of the financial results for the quarter and half year ended September 30, 2026 路 31 Oct 2026
- Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the audio recording of the Company's .... 路 31 Oct 2026
- Communication to shareholders-Intimation regarding Tax Deduction on Dividend 路 30 Oct 2026
- Investor Presentation for Q2 & H1 of Financial Year 2026-27 路 30 Oct 2026
- Intimation of Record Date for ascertaining Members eligible for the payment of interim dividend for the financial year 2026-2027 路 30 Oct 2026
